Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Platelets Promote Liver Regeneration Following Surgery

By HospiMedica International staff writers
Posted on 09 Dec 2015
A new study finds that platelet-derived growth factors can encourage the liver regeneration process in patients undergoing partial hepatectomy.

Researchers at MedUni Vienna (Austria) conducted a study to investigate the pattern of liver regeneration in 157 patients who had a part of their liver removed. More...
Plasma levels of circulating platelet α-granule-derived factors in the liver vein were measured at the end of liver resection, as well as on the first postoperative day. The granules contain both growth-promoting and growth-inhibiting factors, including vascular endothelial growth factor (VEGF) and thrombospondin-1 (TSP-1). The researchers found that a rapid accumulation of platelets occurred within the liver after induction of liver regeneration.

The results showed that even though platelet count was not associated with postoperative liver dysfunction, patients with an unfavorable postoperative plasma α-granule profile (high TSP-1/low VEGF) showed substantially worse postoperative clinical outcomes. The unfavorable postoperative α-granule release profile was also associated with increased postoperative portal venous pressure and von Willebrand factor antigen levels, which serve as a marker for intrahepatic endothelial dysfunction. The study was published on November 3, 2015, in Hepatology.

“The postoperative profile of circulating platelet-derived factors correlates with the ability of the remnant liver to regenerate; portal venous pressure and intrahepatic endothelial dysfunction might account for the selective granule release profile,” concluded lead author Patrick Starlinger, MD, PhD, of the department of surgery, and colleagues. “Selective modulation of platelet α-granule release in patients may represent an attractive target for therapeutic interventions to improve liver regeneration and clinical outcomes after partial hepatectomy.”

Liver regeneration following partial hepatectomy is a complex and well-orchestrated phenomenon involving all mature liver cell types, and is associated with signaling cascades involving growth factors, cytokines, matrix remodeling, and several feedback circuits of stimulation and inhibition of growth related signals. The liver manages to restore any lost mass and adjust its size to that of the organism, while at the same time providing full support for body homeostasis during the entire regenerative process.

Related Links:

MedUni Vienna



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.